Finally, we observed HER3 upregulation in EGFR-mutated NSCLC cell lines treated with EGFR-TKIs and in tumor samples obtained from patients with EGFR-mutated NSCLC treated with EGFR-TKIs [30,31] (Figure 1). This evidence concerns the gene ERBB3 and neoplasm.